• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Contraceptive Drugs and Devices Market Insights and Forecast to 2026

report cover
  • 30 July 2020
  • Healthcare
  • 117 Pages
  • Report Code: 24LS-16040
  • Formate :   
Download FREE Report Sample Download PDF File

Contraceptive Drugs Devices -MARKET ADVISORY SERVICES

Contraceptive Drugs and Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Contraceptive Drugs and Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Contraceptive Drugs and Devices market is segmented into
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices

Segment by Application, the Contraceptive Drugs and Devices market is segmented into
Hospitals
Pharmacies
Others

Regional and Country-level Analysis
The Contraceptive Drugs and Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Contraceptive Drugs and Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Contraceptive Drugs and Devices Market Share Analysis
Contraceptive Drugs and Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Contraceptive Drugs and Devices business, the date to enter into the Contraceptive Drugs and Devices market, Contraceptive Drugs and Devices product introduction, recent developments, etc.

The major vendors covered:
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
1 Study Coverage
1.1 Contraceptive Drugs and Devices Product Introduction
1.2 Market Segments
1.3 Key Contraceptive Drugs and Devices Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Vaginal
1.4.4 Injectable Contraceptive Drugs
1.4.5 Male/Female Contraceptive Devices
1.5 Market by Application
1.5.1 Global Contraceptive Drugs and Devices Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Contraceptive Drugs and Devices Market Size, Estimates and Forecasts
2.1.1 Global Contraceptive Drugs and Devices Revenue 2015-2026
2.1.2 Global Contraceptive Drugs and Devices Sales 2015-2026
2.2 Global Contraceptive Drugs and Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Contraceptive Drugs and Devices Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Contraceptive Drugs and Devices Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Contraceptive Drugs and Devices Competitor Landscape by Players
3.1 Contraceptive Drugs and Devices Sales by Manufacturers
3.1.1 Contraceptive Drugs and Devices Sales by Manufacturers (2015-2020)
3.1.2 Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2015-2020)
3.2 Contraceptive Drugs and Devices Revenue by Manufacturers
3.2.1 Contraceptive Drugs and Devices Revenue by Manufacturers (2015-2020)
3.2.2 Contraceptive Drugs and Devices Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Contraceptive Drugs and Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Contraceptive Drugs and Devices Revenue in 2019
3.2.5 Global Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Contraceptive Drugs and Devices Price by Manufacturers
3.4 Contraceptive Drugs and Devices Manufacturing Base Distribution, Product Types
3.4.1 Contraceptive Drugs and Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contraceptive Drugs and Devices Product Type
3.4.3 Date of International Manufacturers Enter into Contraceptive Drugs and Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Contraceptive Drugs and Devices Market Size by Type (2015-2020)
4.1.1 Global Contraceptive Drugs and Devices Sales by Type (2015-2020)
4.1.2 Global Contraceptive Drugs and Devices Revenue by Type (2015-2020)
4.1.3 Contraceptive Drugs and Devices Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Contraceptive Drugs and Devices Market Size Forecast by Type (2021-2026)
4.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Type (2021-2026)
4.2.3 Contraceptive Drugs and Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Contraceptive Drugs and Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Contraceptive Drugs and Devices Market Size by Application (2015-2020)
5.1.1 Global Contraceptive Drugs and Devices Sales by Application (2015-2020)
5.1.2 Global Contraceptive Drugs and Devices Revenue by Application (2015-2020)
5.1.3 Contraceptive Drugs and Devices Price by Application (2015-2020)
5.2 Contraceptive Drugs and Devices Market Size Forecast by Application (2021-2026)
5.2.1 Global Contraceptive Drugs and Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Contraceptive Drugs and Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Contraceptive Drugs and Devices Price Forecast by Application (2021-2026)

6 North America
6.1 North America Contraceptive Drugs and Devices by Country
6.1.1 North America Contraceptive Drugs and Devices Sales by Country
6.1.2 North America Contraceptive Drugs and Devices Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Contraceptive Drugs and Devices Market Facts & Figures by Type
6.3 North America Contraceptive Drugs and Devices Market Facts & Figures by Application

7 Europe
7.1 Europe Contraceptive Drugs and Devices by Country
7.1.1 Europe Contraceptive Drugs and Devices Sales by Country
7.1.2 Europe Contraceptive Drugs and Devices Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contraceptive Drugs and Devices Market Facts & Figures by Type
7.3 Europe Contraceptive Drugs and Devices Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Contraceptive Drugs and Devices by Region
8.1.1 Asia Pacific Contraceptive Drugs and Devices Sales by Region
8.1.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Contraceptive Drugs and Devices Market Facts & Figures by Type
8.3 Asia Pacific Contraceptive Drugs and Devices Market Facts & Figures by Application

9 Latin America
9.1 Latin America Contraceptive Drugs and Devices by Country
9.1.1 Latin America Contraceptive Drugs and Devices Sales by Country
9.1.2 Latin America Contraceptive Drugs and Devices Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Contraceptive Drugs and Devices Market Facts & Figures by Type
9.3 Central & South America Contraceptive Drugs and Devices Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Contraceptive Drugs and Devices by Country
10.1.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Country
10.1.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Contraceptive Drugs and Devices Market Facts & Figures by Type
10.3 Middle East and Africa Contraceptive Drugs and Devices Market Facts & Figures by Application

11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Description and Business Overview
11.1.3 Bayer Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Healthcare Contraceptive Drugs and Devices Products Offered
11.1.5 Bayer Healthcare Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Contraceptive Drugs and Devices Products Offered
11.2.5 Merck Related Developments
11.3 Church & Dwight
11.3.1 Church & Dwight Corporation Information
11.3.2 Church & Dwight Description and Business Overview
11.3.3 Church & Dwight Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Church & Dwight Contraceptive Drugs and Devices Products Offered
11.3.5 Church & Dwight Related Developments
11.4 Warmer Chilcott
11.4.1 Warmer Chilcott Corporation Information
11.4.2 Warmer Chilcott Description and Business Overview
11.4.3 Warmer Chilcott Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Warmer Chilcott Contraceptive Drugs and Devices Products Offered
11.4.5 Warmer Chilcott Related Developments
11.5 Agile Therapeutics
11.5.1 Agile Therapeutics Corporation Information
11.5.2 Agile Therapeutics Description and Business Overview
11.5.3 Agile Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Agile Therapeutics Contraceptive Drugs and Devices Products Offered
11.5.5 Agile Therapeutics Related Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description and Business Overview
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Contraceptive Drugs and Devices Products Offered
11.6.5 Pfizer Related Developments
11.7 BioSante Pharmaceuticals
11.7.1 BioSante Pharmaceuticals Corporation Information
11.7.2 BioSante Pharmaceuticals Description and Business Overview
11.7.3 BioSante Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Products Offered
11.7.5 BioSante Pharmaceuticals Related Developments
11.8 Mayer Laboratories
11.8.1 Mayer Laboratories Corporation Information
11.8.2 Mayer Laboratories Description and Business Overview
11.8.3 Mayer Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mayer Laboratories Contraceptive Drugs and Devices Products Offered
11.8.5 Mayer Laboratories Related Developments
11.9 Pantarhei Bioscience
11.9.1 Pantarhei Bioscience Corporation Information
11.9.2 Pantarhei Bioscience Description and Business Overview
11.9.3 Pantarhei Bioscience Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Products Offered
11.9.5 Pantarhei Bioscience Related Developments
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Corporation Information
11.10.2 Teva Pharmaceutical Industries Description and Business Overview
11.10.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Products Offered
11.10.5 Teva Pharmaceutical Industries Related Developments
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Description and Business Overview
11.1.3 Bayer Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Healthcare Contraceptive Drugs and Devices Products Offered
11.1.5 Bayer Healthcare Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Contraceptive Drugs and Devices Market Estimates and Projections by Region
12.1.1 Global Contraceptive Drugs and Devices Sales Forecast by Regions 2021-2026
12.1.2 Global Contraceptive Drugs and Devices Revenue Forecast by Regions 2021-2026
12.2 North America Contraceptive Drugs and Devices Market Size Forecast (2021-2026)
12.2.1 North America: Contraceptive Drugs and Devices Sales Forecast (2021-2026)
12.2.2 North America: Contraceptive Drugs and Devices Revenue Forecast (2021-2026)
12.2.3 North America: Contraceptive Drugs and Devices Market Size Forecast by Country (2021-2026)
12.3 Europe Contraceptive Drugs and Devices Market Size Forecast (2021-2026)
12.3.1 Europe: Contraceptive Drugs and Devices Sales Forecast (2021-2026)
12.3.2 Europe: Contraceptive Drugs and Devices Revenue Forecast (2021-2026)
12.3.3 Europe: Contraceptive Drugs and Devices Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Contraceptive Drugs and Devices Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Contraceptive Drugs and Devices Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Contraceptive Drugs and Devices Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Contraceptive Drugs and Devices Market Size Forecast by Region (2021-2026)
12.5 Latin America Contraceptive Drugs and Devices Market Size Forecast (2021-2026)
12.5.1 Latin America: Contraceptive Drugs and Devices Sales Forecast (2021-2026)
12.5.2 Latin America: Contraceptive Drugs and Devices Revenue Forecast (2021-2026)
12.5.3 Latin America: Contraceptive Drugs and Devices Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Contraceptive Drugs and Devices Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Contraceptive Drugs and Devices Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Contraceptive Drugs and Devices Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Contraceptive Drugs and Devices Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Contraceptive Drugs and Devices Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Contraceptive Drugs and Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Contraceptive Drugs and Devices Market Segments

Table 2. Ranking of Global Top Contraceptive Drugs and Devices Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Contraceptive Drugs and Devices Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Oral

Table 5. Major Manufacturers of Vaginal

Table 6. Major Manufacturers of Injectable Contraceptive Drugs

Table 7. Major Manufacturers of Male/Female Contraceptive Devices

Table 8. Global Contraceptive Drugs and Devices Market Size Growth Rate by Application 2020-2026 (K Units)

Table 9. Global Contraceptive Drugs and Devices Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 10. Global Contraceptive Drugs and Devices Sales by Regions 2015-2020 (K Units)

Table 11. Global Contraceptive Drugs and Devices Sales Market Share by Regions (2015-2020)

Table 12. Global Contraceptive Drugs and Devices Revenue by Regions 2015-2020 (US$ Million)

Table 13. Global Contraceptive Drugs and Devices Sales by Manufacturers (2015-2020) (K Units)

Table 14. Global Contraceptive Drugs and Devices Sales Share by Manufacturers (2015-2020)

Table 15. Global Contraceptive Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 16. Global Contraceptive Drugs and Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contraceptive Drugs and Devices as of 2019)

Table 17. Contraceptive Drugs and Devices Revenue by Manufacturers (2015-2020) (US$ Million)

Table 18. Contraceptive Drugs and Devices Revenue Share by Manufacturers (2015-2020)

Table 19. Key Manufacturers Contraceptive Drugs and Devices Price (2015-2020) (USD/Unit)

Table 20. Contraceptive Drugs and Devices Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Contraceptive Drugs and Devices Product Type

Table 22. Date of International Manufacturers Enter into Contraceptive Drugs and Devices Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. Global Contraceptive Drugs and Devices Sales by Type (2015-2020) (K Units)

Table 25. Global Contraceptive Drugs and Devices Sales Share by Type (2015-2020)

Table 26. Global Contraceptive Drugs and Devices Revenue by Type (2015-2020) (US$ Million)

Table 27. Global Contraceptive Drugs and Devices Revenue Share by Type (2015-2020)

Table 28. Contraceptive Drugs and Devices Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 29. Global Contraceptive Drugs and Devices Sales by Application (2015-2020) (K Units)

Table 30. Global Contraceptive Drugs and Devices Sales Share by Application (2015-2020)

Table 31. North America Contraceptive Drugs and Devices Sales by Country (2015-2020) (K Units)

Table 32. North America Contraceptive Drugs and Devices Sales Market Share by Country (2015-2020)

Table 33. North America Contraceptive Drugs and Devices Revenue by Country (2015-2020) (US$ Million)

Table 34. North America Contraceptive Drugs and Devices Revenue Market Share by Country (2015-2020)

Table 35. North America Contraceptive Drugs and Devices Sales by Type (2015-2020) (K Units)

Table 36. North America Contraceptive Drugs and Devices Sales Market Share by Type (2015-2020)

Table 37. North America Contraceptive Drugs and Devices Sales by Application (2015-2020) (K Units)

Table 38. North America Contraceptive Drugs and Devices Sales Market Share by Application (2015-2020)

Table 39. Europe Contraceptive Drugs and Devices Sales by Country (2015-2020) (K Units)

Table 40. Europe Contraceptive Drugs and Devices Sales Market Share by Country (2015-2020)

Table 41. Europe Contraceptive Drugs and Devices Revenue by Country (2015-2020) (US$ Million)

Table 42. Europe Contraceptive Drugs and Devices Revenue Market Share by Country (2015-2020)

Table 43. Europe Contraceptive Drugs and Devices Sales by Type (2015-2020) (K Units)

Table 44. Europe Contraceptive Drugs and Devices Sales Market Share by Type (2015-2020)

Table 45. Europe Contraceptive Drugs and Devices Sales by Application (2015-2020) (K Units)

Table 46. Europe Contraceptive Drugs and Devices Sales Market Share by Application (2015-2020)

Table 47. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2015-2020) (K Units)

Table 48. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Region (2015-2020)

Table 49. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2015-2020) (US$ Million)

Table 50. Asia Pacific Contraceptive Drugs and Devices Revenue Market Share by Region (2015-2020)

Table 51. Asia Pacific Contraceptive Drugs and Devices Sales by Type (2015-2020) (K Units)

Table 52. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Type (2015-2020)

Table 53. Asia Pacific Contraceptive Drugs and Devices Sales by Application (2015-2020) (K Units)

Table 54. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Application (2015-2020)

Table 55. Latin America Contraceptive Drugs and Devices Sales by Country (2015-2020) (K Units)

Table 56. Latin America Contraceptive Drugs and Devices Sales Market Share by Country (2015-2020)

Table 57. Latin Americaa Contraceptive Drugs and Devices Revenue by Country (2015-2020) (US$ Million)

Table 58. Latin America Contraceptive Drugs and Devices Revenue Market Share by Country (2015-2020)

Table 59. Latin America Contraceptive Drugs and Devices Sales by Type (2015-2020) (K Units)

Table 60. Latin America Contraceptive Drugs and Devices Sales Market Share by Type (2015-2020)

Table 61. Latin America Contraceptive Drugs and Devices Sales by Application (2015-2020) (K Units)

Table 62. Latin America Contraceptive Drugs and Devices Sales Market Share by Application (2015-2020)

Table 63. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2015-2020) (K Units)

Table 64. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Country (2015-2020)

Table 65. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2015-2020) (US$ Million)

Table 66. Middle East and Africa Contraceptive Drugs and Devices Revenue Market Share by Country (2015-2020)

Table 67. Middle East and Africa Contraceptive Drugs and Devices Sales by Type (2015-2020) (K Units)

Table 68. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Type (2015-2020)

Table 69. Middle East and Africa Contraceptive Drugs and Devices Sales by Application (2015-2020) (K Units)

Table 70. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Application (2015-2020)

Table 71. Bayer Healthcare Corporation Information

Table 72. Bayer Healthcare Description and Major Businesses

Table 73. Bayer Healthcare Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 74. Bayer Healthcare Product

Table 75. Bayer Healthcare Recent Development

Table 76. Merck Corporation Information

Table 77. Merck Description and Major Businesses

Table 78. Merck Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 79. Merck Product

Table 80. Merck Recent Development

Table 81. Church & Dwight Corporation Information

Table 82. Church & Dwight Description and Major Businesses

Table 83. Church & Dwight Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 84. Church & Dwight Product

Table 85. Church & Dwight Recent Development

Table 86. Warmer Chilcott Corporation Information

Table 87. Warmer Chilcott Description and Major Businesses

Table 88. Warmer Chilcott Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 89. Warmer Chilcott Product

Table 90. Warmer Chilcott Recent Development

Table 91. Agile Therapeutics Corporation Information

Table 92. Agile Therapeutics Description and Major Businesses

Table 93. Agile Therapeutics Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 94. Agile Therapeutics Product

Table 95. Agile Therapeutics Recent Development

Table 96. Pfizer Corporation Information

Table 97. Pfizer Description and Major Businesses

Table 98. Pfizer Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 99. Pfizer Product

Table 100. Pfizer Recent Development

Table 101. BioSante Pharmaceuticals Corporation Information

Table 102. BioSante Pharmaceuticals Description and Major Businesses

Table 103. BioSante Pharmaceuticals Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 104. BioSante Pharmaceuticals Product

Table 105. BioSante Pharmaceuticals Recent Development

Table 106. Mayer Laboratories Corporation Information

Table 107. Mayer Laboratories Description and Major Businesses

Table 108. Mayer Laboratories Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 109. Mayer Laboratories Product

Table 110. Mayer Laboratories Recent Development

Table 111. Pantarhei Bioscience Corporation Information

Table 112. Pantarhei Bioscience Description and Major Businesses

Table 113. Pantarhei Bioscience Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 114. Pantarhei Bioscience Product

Table 115. Pantarhei Bioscience Recent Development

Table 116. Teva Pharmaceutical Industries Corporation Information

Table 117. Teva Pharmaceutical Industries Description and Major Businesses

Table 118. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 119. Teva Pharmaceutical Industries Product

Table 120. Teva Pharmaceutical Industries Recent Development

Table 121. Global Contraceptive Drugs and Devices Sales Forecast by Regions (2021-2026) (K Units)

Table 122. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Regions (2021-2026)

Table 123. Global Contraceptive Drugs and Devices Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 124. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Regions (2021-2026)

Table 125. North America: Contraceptive Drugs and Devices Sales Forecast by Country (2021-2026) (K Units)

Table 126. North America: Contraceptive Drugs and Devices Revenue Forecast by Country (2021-2026) (US$ Million)

Table 127. Europe: Contraceptive Drugs and Devices Sales Forecast by Country (2021-2026) (K Units)

Table 128. Europe: Contraceptive Drugs and Devices Revenue Forecast by Country (2021-2026) (US$ Million)

Table 129. Asia Pacific: Contraceptive Drugs and Devices Sales Forecast by Region (2021-2026) (K Units)

Table 130. Asia Pacific: Contraceptive Drugs and Devices Revenue Forecast by Region (2021-2026) (US$ Million)

Table 131. Latin America: Contraceptive Drugs and Devices Sales Forecast by Country (2021-2026) (K Units)

Table 132. Latin America: Contraceptive Drugs and Devices Revenue Forecast by Country (2021-2026) (US$ Million)

Table 133. Middle East and Africa: Contraceptive Drugs and Devices Sales Forecast by Country (2021-2026) (K Units)

Table 134. Middle East and Africa: Contraceptive Drugs and Devices Revenue Forecast by Country (2021-2026) (US$ Million)

Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 136. Key Challenges

Table 137. Market Risks

Table 138. Main Points Interviewed from Key Contraceptive Drugs and Devices Players

Table 139. Contraceptive Drugs and Devices Customers List

Table 140. Contraceptive Drugs and Devices Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Contraceptive Drugs and Devices Product Picture

Figure 2. Global Contraceptive Drugs and Devices Sales Market Share by Type in 2020 & 2026

Figure 3. Oral Product Picture

Figure 4. Vaginal Product Picture

Figure 5. Injectable Contraceptive Drugs Product Picture

Figure 6. Male/Female Contraceptive Devices Product Picture

Figure 7. Global Contraceptive Drugs and Devices Sales Market Share by Application in 2020 & 2026

Figure 8. Hospitals

Figure 9. Pharmacies

Figure 10. Others

Figure 11. Contraceptive Drugs and Devices Report Years Considered

Figure 12. Global Contraceptive Drugs and Devices Market Size 2015-2026 (US$ Million)

Figure 13. Global Contraceptive Drugs and Devices Sales 2015-2026 (K Units)

Figure 14. Global Contraceptive Drugs and Devices Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Contraceptive Drugs and Devices Sales Market Share by Region (2015-2020)

Figure 16. Global Contraceptive Drugs and Devices Sales Market Share by Region in 2019

Figure 17. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2015-2020)

Figure 18. Global Contraceptive Drugs and Devices Revenue Market Share by Region in 2019

Figure 19. Global Contraceptive Drugs and Devices Sales Share by Manufacturer in 2019

Figure 20. The Top 10 and 5 Players Market Share by Contraceptive Drugs and Devices Revenue in 2019

Figure 21. Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Contraceptive Drugs and Devices Sales Market Share by Type (2015-2020)

Figure 23. Global Contraceptive Drugs and Devices Sales Market Share by Type in 2019

Figure 24. Global Contraceptive Drugs and Devices Revenue Market Share by Type (2015-2020)

Figure 25. Global Contraceptive Drugs and Devices Revenue Market Share by Type in 2019

Figure 26. Global Contraceptive Drugs and Devices Market Share by Price Range (2015-2020)

Figure 27. Global Contraceptive Drugs and Devices Sales Market Share by Application (2015-2020)

Figure 28. Global Contraceptive Drugs and Devices Sales Market Share by Application in 2019

Figure 29. Global Contraceptive Drugs and Devices Revenue Market Share by Application (2015-2020)

Figure 30. Global Contraceptive Drugs and Devices Revenue Market Share by Application in 2019

Figure 31. North America Contraceptive Drugs and Devices Sales Growth Rate 2015-2020 (K Units)

Figure 32. North America Contraceptive Drugs and Devices Revenue Growth Rate 2015-2020 (US$ Million)

Figure 33. North America Contraceptive Drugs and Devices Sales Market Share by Country in 2019

Figure 34. North America Contraceptive Drugs and Devices Revenue Market Share by Country in 2019

Figure 35. U.S. Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 36. U.S. Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 37. Canada Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 38. Canada Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 39. North America Contraceptive Drugs and Devices Market Share by Type in 2019

Figure 40. North America Contraceptive Drugs and Devices Market Share by Application in 2019

Figure 41. Europe Contraceptive Drugs and Devices Sales Growth Rate 2015-2020 (K Units)

Figure 42. Europe Contraceptive Drugs and Devices Revenue Growth Rate 2015-2020 (US$ Million)

Figure 43. Europe Contraceptive Drugs and Devices Sales Market Share by Country in 2019

Figure 44. Europe Contraceptive Drugs and Devices Revenue Market Share by Country in 2019

Figure 45. Germany Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 46. Germany Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. France Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 48. France Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 49. U.K. Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 50. U.K. Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. Italy Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 52. Italy Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. Russia Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 54. Russia Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Europe Contraceptive Drugs and Devices Market Share by Type in 2019

Figure 56. Europe Contraceptive Drugs and Devices Market Share by Application in 2019

Figure 57. Asia Pacific Contraceptive Drugs and Devices Sales Growth Rate 2015-2020 (K Units)

Figure 58. Asia Pacific Contraceptive Drugs and Devices Revenue Growth Rate 2015-2020 (US$ Million)

Figure 59. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Region in 2019

Figure 60. Asia Pacific Contraceptive Drugs and Devices Revenue Market Share by Region in 2019

Figure 61. China Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 62. China Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 63. Japan Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 64. Japan Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. South Korea Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 66. South Korea Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. India Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 68. India Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. Australia Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 70. Australia Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. Taiwan Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 72. Taiwan Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Indonesia Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 74. Indonesia Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Thailand Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 76. Thailand Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Malaysia Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 78. Malaysia Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Philippines Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 80. Philippines Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Vietnam Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 82. Vietnam Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Asia Pacific Contraceptive Drugs and Devices Market Share by Type in 2019

Figure 84. Asia Pacific Contraceptive Drugs and Devices Market Share by Application in 2019

Figure 85. Latin America Contraceptive Drugs and Devices Sales Growth Rate 2015-2020 (K Units)

Figure 86. Latin America Contraceptive Drugs and Devices Revenue Growth Rate 2015-2020 (US$ Million)

Figure 87. Latin America Contraceptive Drugs and Devices Sales Market Share by Country in 2019

Figure 88. Latin America Contraceptive Drugs and Devices Revenue Market Share by Country in 2019

Figure 89. Mexico Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 90. Mexico Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 91. Brazil Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 92. Brazil Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Argentina Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 94. Argentina Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Latin America Contraceptive Drugs and Devices Market Share by Type in 2019

Figure 96. Latin America Contraceptive Drugs and Devices Market Share by Application in 2019

Figure 97. Middle East and Africa Contraceptive Drugs and Devices Sales Growth Rate 2015-2020 (K Units)

Figure 98. Middle East and Africa Contraceptive Drugs and Devices Revenue Growth Rate 2015-2020 (US$ Million)

Figure 99. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Country in 2019

Figure 100. Middle East and Africa Contraceptive Drugs and Devices Revenue Market Share by Country in 2019

Figure 101. Turkey Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 102. Turkey Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. Saudi Arabia Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 104. Saudi Arabia Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. U.A.E Contraceptive Drugs and Devices Sales Growth Rate (2015-2020) (K Units)

Figure 106. U.A.E Contraceptive Drugs and Devices Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Middle East and Africa Contraceptive Drugs and Devices Market Share by Type in 2019

Figure 108. Middle East and Africa Contraceptive Drugs and Devices Market Share by Application in 2019

Figure 109. North America Contraceptive Drugs and Devices Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 110. North America Contraceptive Drugs and Devices Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 111. Europe Contraceptive Drugs and Devices Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 112. Europe Contraceptive Drugs and Devices Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 113. Asia Pacific Contraceptive Drugs and Devices Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 114. Asia Pacific Contraceptive Drugs and Devices Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 115. Latin America Contraceptive Drugs and Devices Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 116. Latin America Contraceptive Drugs and Devices Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 117. Middle East and Africa Contraceptive Drugs and Devices Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 118. Middle East and Africa Contraceptive Drugs and Devices Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 119. Porter's Five Forces Analysis

Figure 120. Channels of Distribution

Figure 121. Distributors Profiles

Figure 122. Bottom-up and Top-down Approaches for This Report

Figure 123. Data Triangulation

Figure 124. Key Executives Interviewed

Bayer Healthcare

Merck

Church & Dwight

Warmer Chilcott

Agile Therapeutics

Pfizer

BioSante Pharmaceuticals

Mayer Laboratories

Pantarhei Bioscience

Teva Pharmaceutical Industries

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3159

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase